(SGRY, UNH, HCA, THC) – Assessing Short & Longer-Term Implications of COVID-19 on U.S. ASCs & Surgical Hospitals

(SGRY, UNH, HCA, THC) – Assessing Short & Longer-Term Implications of COVID-19 on U.S. ASCs & Surgical Hospitals

Oh how quickly things can change in a few weeks’ time. Infectious disease and epidemiology experts have long since warned how unprepared the U.S. healthcare system was for coronavirus, but just how unprepared would have been near impossible to fathom. The ambulatory surgery center/surgical hospital landscape is one of many to have been dealt a major blow in the age of COVID-19, as investors are currently scrambling to make sense of the waves of policy changes rippling through. As JP Morgan’s Gary Taylor recently noted on March 26, “[hospital/facility] channel checks this week have been extremely sobering… We are hearing numbers like this from the trailing 1-2 weeks: total revenues down 40-60%, ER visits down 25-30%, inpatient surgical volumes down 30-50%, outpatient surgical volumes and procedures down 50%+, ASC procedures down 70%+.” The spotlight on patient care occurring outside of a hospital’s four walls will undoubtedly intensify as the pandemic unfolds further and hospitals fill to capacity. On the call, our expert shares their unique insight into the space as we are forced to revise expectations and hunker down for the immediately foreseeable future.

This call was hosted on April 9, 2020, under the title: “(SGRY, UNH, HCA, THC) – Assessing Short & Longer-Term Implications of COVID-19 on U.S. ASCs & Surgical Hospitals.”

You can request a replay & transcript of the Hosted Event discussed above, or any of our Hosted Events, by emailing [email protected].

Coleman Research Group, Inc. (“Coleman” or the “Firm”) sponsors events featuring a wide range of speakers (“Guest Speakers”). The opinions, estimates, projections, and views contained in this summary are those of, and exclusively sourced from, the Guest Speakers and are not reviewed or endorsed by the Guest Speakers.  In respect of this summary, Coleman makes no representation or warranty, express or implied, is not providing investment, legal, tax, financial, or accounting advice, and accepts no liability whatsoever. Coleman retains sole discretion as it relates to accessing this information by clients and prospective clients.